Study to provide access to fingolimod to Multiple Sclerosis patients w
An open-label, single arm study to provide access to fingolimod to MS patients who completed fingolimod phase IIIb studies and who benefited from treatment with fingolimod or do not have suitable alternative treatment options, but do not have access to the reimbursed drug
What it found
The trial ended early for another reason (see below).
What was tested
Treatment tested
What it measured
Main measures
to provide access to fingolimod to patients who completed local or global fingolimod phase IIIb studies in MS who benefited from treatment with fingolimod or do not have suitable alternative treatment options but do not have access to the reimbursed drug.
Other measures (1)
to generate long-term safety and tolerability data in a population different from that of the EMA approved label and routine medical care.
Safety
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
Inclusion: Patients eligible for inclusion in this program have to meet all of the following criteria: Exclusion: Patients meeting any of the following criteria are not eligible for inclusion in the study:
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
- to provide access to fingolimod to patients who completed local or global fingolimod phase IIIb studies in MS who benefited from treatment with fingolimod or do not have suitable alternative treatment options but do not have access to the reimbursed drug.
Loading reviews and guidelines…
Related trials
- Risk of Progressive Multifocal Leukoencephalopathy Among Patients With
Recruiting
Still running
- Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Scle
Phase 4 · Status unknown
No results found
- Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hy
Recruiting
Still running
- Monitoring of drugs used in the treatment of multiple sclerosis
Phase 4 · Completed
No results found
- Observational Study of the Effect of Ozanimod on Fatigue in Multiple S
Stopped early
Stopped
- Post-Authorization Safety Study for Assessment of Pregnancy Outcomes i
Recruiting
Still running
History
Started
Feb 2013